Skip to main content
TipRanks
Go Ultimate75% OFF

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315) Ownership - Who Owns Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H?

1 Followers

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315) Ownership Overview

  • 0.14% Mutual Funds
  • 0.42% ETFs
  • 99.44% Public Companies and Individual Investors

The ownership structure of Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315) stock is a mix of institutional, retail, and individual investors. Approximately 0.56% of the company’s stock is owned by Institutional Investors, and 99.44% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

HK:2315 top shareholders
Holder# of SharesType% HoldingValue
First Trust394,000Institution0.36%2,079,138
Dfa Investment Dimensions Group Inc98,000Institution0.09%517,146
Fidelity Rutland Square Trust Ii29,093Institution0.03%153,524
Amundi27,792Institution0.03%146,658
Goldman Sachs Trust23,000Institution0.02%121,371
Avantis18,500Institution0.02%97,625
Dimensional8,500Institution<0.01%44,855
Catholic Responsible Investments Funds6,500Institution<0.01%34,301
State Street5,500Institution<0.01%29,024
Jpmorgan3,500Institution<0.01%18,470

Top Mutual Fund Holders

HK:2315 top mutual fund holders
Holder# of SharesType% HoldingValue
Dfa Investment Dimensions Group Inc98,000Institution0.09%517,146
Fidelity Rutland Square Trust Ii29,093Institution0.03%153,524
Goldman Sachs Trust23,000Institution0.02%121,371
Catholic Responsible Investments Funds6,500Institution<0.01%34,301

Top ETF Holders

FAQ

What percentage of Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.56% of Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315) stock is held by institutional investors: 0.14% by mutual funds and 0.42% by ETFs.
What percentage of Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.44% of Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315) stock is held by public companies and individual investors.
Who owns the most shares of Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315)?
First Trust owns the most shares of Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.